Neomate 2 is a neonatal reference and calculation app for NICU clinical staff.
This is an alpha evaluation and clinical review version. It is not ready or approved for clinical use. Do not use its content or calculations for patient care, distribute a build for clinical use, or represent its outputs as clinically validated until the clinical-safety, quality-management, evidence-review, and release gates in SAFETY.md are complete.
Install mise, then run:
s/setup
s/lint
s/test.mise.toml pins the exact Flutter SDK version; s/setup installs it and fetches dependencies.
The current non-clinical demonstration scope, build commands, and limitations are documented in spec/internal-alpha.md.
- SAFETY.md - clinical safety status and entry point.
- clinical-safety/ - safety plan, safety case, and hazard log.
- qms/ - software-development and release controls.
- spec/ - durable product, terminology, and roadmap decisions.
- Clinical review questions - prioritised decisions for neonatal clinical reviewers.
- agent-instructions.md - contributor and agent workflow.
The current contributors are listed alphabetically:
- Dr Marcus Baw
- Michael Barton - RCPCH Lead Developer
- Dr Katharine Jamieson - Neonatal consultant
- Dr Chris Kelly - Doctor, Guy's and St Thomas' Hospital
- Dr Lee Collier, STORKS Charity, Blizard Institute Queen Mary University of London
- Dr Syed Mohinuddin - Neonatal consultant, Children's Hospital of Eastern Ontario (CHEO)
New Neomate 2 code and project artefacts are Copyright (c) 2026 Neomate team and RCPCH, licensed under the GNU Affero General Public License v3.0 or later. Written documentation produced for this project is CC-BY-SA-4.0. Rights in inherited Neomate-owned material have been transferred to RCPCH for continued maintenance and redistribution.
Third-party material retains its existing rights and licence requirements. Publication of the source code does not constitute clinical approval; distribution or deployment for clinical use remains prohibited until the documented clinical-governance, safety, quality, and regulatory gates are met.